{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:28:37Z","timestamp":1784752117912,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["2022-1 DEV \/ 14299"],"award-info":[{"award-number":["2022-1 DEV \/ 14299"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1136\/ijgc-2024-005493","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T13:10:25Z","timestamp":1715001025000},"page":"1639-1642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Primary chemoradiation versus neoadjuvant chemotherapy followed by surgery as treatment strategy for locally advanced vulvar carcinoma (VULCANize2)"],"prefix":"10.1016","volume":"34","clinical-trial-number":[{"clinical-trial-number":"nct05905315","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5452-4905","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Amant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7421-1237","authenticated-orcid":false,"given":"Anne Fleur","family":"van Velzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Reyners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Zijlmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva E","family":"Schaake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5741-4595","authenticated-orcid":false,"given":"Linda","family":"Nooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2024-005493_bb0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2020.05.021","article-title":"Locally advanced squamous cell carcinoma of the vulva: A challenging question for gynecologic oncologists","volume":"158","author":"Gadducci","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005493_bb0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11912-013-0349-x","article-title":"Unresectable vulval cancers: is neoadjuvant chemotherapy the way forward","volume":"15","author":"Graham","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"10.1136\/ijgc-2024-005493_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011786","article-title":"Clinical analysis of neoadjuvant chemotherapy in patients with advanced vulvar cancer: A STROBE-compliant article","volume":"97","author":"Niu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ijgc-2024-005493_bb0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/14737140.2015.1037837","article-title":"Systemic treatment of vulvar cancer","volume":"15","author":"Mahner","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1136\/ijgc-2024-005493_bb0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2019.02.002","article-title":"Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study","volume":"153","author":"Matsuo","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005493_bb0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.critrevonc.2006.06.009","article-title":"Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer","volume":"60","author":"Gadducci","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1136\/ijgc-2024-005493_bb0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.6004\/jnccn.2017.0008","article-title":"Vulvar cancer, version 1.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Koh","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1136\/ijgc-2024-005493_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003752.pub3","article-title":"Chemoradiation for advanced primary vulval cancer","author":"Shylasree","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2024-005493_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003752.pub2","article-title":"Neoadjuvant chemoradiation for advanced primary vulvar cancer","author":"van Doorn","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2024-005493_bb0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/03008916211027627","article-title":"Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience","volume":"108","author":"Adorni","year":"2022","journal-title":"Tumori"},{"key":"10.1136\/ijgc-2024-005493_bb0060","article-title":"Neoadjuvant chemotherapy with paclitaxel\/carboplatin\/bevacizumab in advanced vulvar cancer: time to rethink standard of care","volume":"34","author":"Klavans","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2024-005493_bb0065","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1159\/000487435","article-title":"Brief report on 3-weekly paclitaxel carboplatin efficacy in locally advanced or metastatic squamous vulvar cancer","volume":"83","author":"Amant","year":"2018","journal-title":"Gynecol Obstet Invest"},{"key":"10.1136\/ijgc-2024-005493_bb0070","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24035795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24035795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2024-005493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:31:10Z","timestamp":1759350670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24035795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1048891X24035795"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2024-005493","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary chemoradiation versus neoadjuvant chemotherapy followed by surgery as treatment strategy for locally advanced vulvar carcinoma (VULCANize2)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2024-005493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}